Back to Investors
UF

UK Future Fund

Government

Portfolio

2

companies


Portfolio companies

CN

Cumulus Neuroscience

Digital biomarker platform provider for neuroscience clinical trials and patient monitoring.

E

EVRYTHNG

EVRYTHNG provides a product cloud platform that manages digital identities for consumer items.


Recent investments

Seed
£6.0M

The financing round was led by the Dementia Discovery Fund with backing from LifeArc and the UK Future Fund.

"We are delighted that DDF and LifeArc share our mission, addressing the clear need for more effective tools to provide the critical clinical trial data and analysis needed to improve the successful delivery of new CNS therapies to patients. This funding will allow us to build on the ground-breaking advances we have made in remote, frequent monitoring of brain activity and cognitive function in the home, in partnership with leading developers of digital biomarkers. We believe our integrated next generation platform can improve the execution of clinical trials by yielding significant time and cost savings, adding meaningful value to the next generation of CNS therapies."
— Ronan Cunningham, CEO
Series B
£7.8M

The funding round was led by IDC Ventures and Simon Eyers to support international expansion and product development.

"COVID-19 has made supply chain transparency and visibility absolutely crucial, not only in retail categories such as apparel, pharma and consumer goods, but in healthcare, government and other sectors as well,"
— Niall Murphy, CEO and Co-founder